Sepsis: pathophysiology and clinical management

JE Gotts, MA Matthay - Bmj, 2016 - bmj.com
Sepsis, severe sepsis, and septic shock represent increasingly severe systemic
inflammatory responses to infection. Sepsis is common in the aging population, and it …

Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view

W Schulte, J Bernhagen, R Bucala - Mediators of inflammation, 2013 - Wiley Online Library
Sepsis and septic shock are among the leading causes of death in intensive care units
worldwide. Numerous studies on their pathophysiology have revealed an imbalance in the …

Regulation of inflammation by short chain fatty acids

MAR Vinolo, HG Rodrigues, RT Nachbar, R Curi - Nutrients, 2011 - mdpi.com
The short chain fatty acids (SCFAs) acetate (C2), propionate (C3) and butyrate (C4) are the
main metabolic products of anaerobic bacteria fermentation in the intestine. In addition to …

Dopamine mediates vagal modulation of the immune system by electroacupuncture

R Torres-Rosas, G Yehia, G Peña, P Mishra… - Nature medicine, 2014 - nature.com
Previous anti-inflammatory strategies against sepsis, a leading cause of death in hospitals,
had limited efficacy in clinical trials, in part because they targeted single cytokines and the …

Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation

DJ Prockop, JY Oh - Molecular therapy, 2012 - cell.com
Recent observations have demonstrated that one of the functions of mesenchymal
stem/stromal cells (MSCs) is to serve as guardians against excessive inflammatory …

Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production

K Németh, A Leelahavanichkul, PST Yuen, B Mayer… - Nature medicine, 2009 - nature.com
Sepsis causes over 200,000 deaths yearly in the US; better treatments are urgently needed.
Administering bone marrow stromal cells (BMSCs—also known as mesenchymal stem cells) …

Role of cytokines as a double-edged sword in sepsis

H Chaudhry, J Zhou, YIN Zhong, MM Ali, F McGuire… - In vivo, 2013 - iv.iiarjournals.org
Background: Sepsis is a deadly immunological disorder and its pathophysiology is still
poorly understood. We aimed to determine if specific pro-inflammatory and anti-inflammatory …

[PDF][PDF] RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome

L Duprez, N Takahashi, F Van Hauwermeiren… - Immunity, 2011 - cell.com
Engagement of tumor necrosis factor receptor 1 signals two diametrically opposed
pathways: survival-inflammation and cell death. An additional switch decides, depending on …

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis

TW Rice, AP Wheeler, GR Bernard… - Critical care …, 2010 - journals.lww.com
Objective: To evaluate whether TAK-242, a small-molecule inhibitor of Toll-like receptor-4–
mediated signaling, suppresses cytokine levels and improves 28-day all-cause mortality …

Animal models of sepsis: setting the stage

JA Buras, B Holzmann, M Sitkovsky - Nature reviews Drug discovery, 2005 - nature.com
Sepsis is a state of disrupted inflammatory homeostasis that is often initiated by infection.
The development and progression of sepsis is multi-factorial, and affects the cardiovascular …